SAN FRANCISCO & SHANGHAI – Driver, a digital platform that connects cancer patients to treatments, has launched in the United States and China to enable patients to access treatment options across a global network of cancer centers without leaving home.
“In a world of Amazon, Airbnb and other technology platforms that have revolutionized our ability to access products and services, consumers deserve the same transformative power of these next-generation marketplaces when they are facing cancer and require treatment,” said Dr. William R. Polkinghorn, co-founder and CEO of Driver, in a statement.
Founded by the U.S. National Cancer Institute and the Chinese National Cancer Center, Driver’s network is comprised of more than 30 cancer centers, including the Cleveland Clinic, Mayo Clinic, Massachusetts General Hospital, University of California San Francisco and others.
“While great advances have been made in personalizing cancer treatments in recent years, many patients are unaware of all of their options,” said Dr. Keith Flaherty, director of the Henri and Belinda Termeer Center for Targeted Therapies at Massachusetts General Hospital, a member of the Driver network, in a statement. “Driver’s approach could revolutionize the way that treatment options are presented to patients at essential junctions in their care.”
Through Driver, patients have the opportunity to review their treatment options over video with an expert oncologist and then can select a hospital within the network for further evaluation. Driver arranges the appointment at each patient’s hospital of choice and delivers their records and other information required for the evaluation.